The Role of Lifestyle in the Co-occurrence of Depression and Hypertension: A Review
Article Sidebar
Main Article Content
Abstract
Depression is a common mental illness and Hypertension is a chronic disease and due to negligence depression in hypertension may accelerate the progression of cardiovascular disease. Compared to the general population, people with depression had a higher incidence of hypertension. Aim to investigate the research on relationship between lifestyle factors and the co-occurrence of depression and hypertension. Database collected from such as Sciencedirect, Researchgate, PubMed, Scopus, and Google Scholar were searched. Control of blood pressure may be difficult in patients with hypertension who are depressed. Screening patients with hypertension for depression is an easy and affordable method that could lead to better results. A key factor in the management of both conditions is lifestyle choices.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
All open access articles published in the journal are distributed under the terms of the CC-BY-NC-SA 4.0 license (Creative Commons Attribution-Non-commercial 4.0 International License) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work is properly cited. Under Creative Commons, authors retain copyright in their articles.
References
Son YJ, Won MH. Depression and medication adherence among older Korean patients with hypertension: Mediating role of self‐efficacy. International journal of nursing practice. 2017 Jun;23(3): e12525.
Kulkarni V., Lingappa S. Prevalence of depression in patients attending general medicine outpatient department for hypertension. International Journal of Medical Science and Public Health.2019; 8(2):105–109.
Mandolikar RY, Naik P, Akram MS, Nirgude AS. Depression among the elderly: a cross-sectional study in an urban community. Int J Med Sci Public Health. 2017 Jan 1;6(2):318-23.
Ginty AT, Carroll D, Roseboom TJ, Phillips AC, de Rooij SR. Depression and anxiety are associated with a diagnosis of hypertension 5 years later in a cohort of late middle-aged men and women. Journal of human hypertension. 2013 Mar;27(3):187-90.
Nejati S, Zahiroddin A, Afrookhteh G, Rahmani S, Hoveida S. Effect of group mindfulness-based stress-reduction program and conscious yoga on lifestyle, coping strategies, and systolic and diastolic blood pressures in patients with hypertension. The Journal of Tehran University Heart Center. 2015 Jul 7;10(3):140.
School Harvard Medical Reading the new blood pressure guidelines. 2018. Apr, Accessed on 20-4 2020.
Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. Journal of hypertension. 2012 May 1;30(5):842-51.
NEMEROFF CB, O'CONNOR CM. Depression as a risk factor for cardiovascular and cerebrovascular disease: emerging data and clinical perspectives. The American heart journal. 2000;140(4).
World Health Organization Depression. 2018. Mar 22, Accessed on 20-4 2020.
Prathibha MT, Varghese S, Jincy J. Prevalence of depression among hypertensive individuals in urban Trivandrum: a cross sectional study. International Journal Of Community Medicine And Public Health. 2017 May 22;4(6):2156-61.
Davidson K, Jonas BS, Dixon KE, Markovitz JH. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study?. Archives of internal medicine. 2000 May 22;160(10):1495-500.
Murphy MB, Murray C, Shorten GD. Fenoldopam—a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. New England Journal of Medicine. 2001 Nov 22;345(21):1548-57.
Mycek MJ, Harvey RA, Champe PC. Antidepressant Drugs. In: Mycek MJ, Harvey RA, Champe PC, editors. Pharmacology. Philadelphia: Lippincott Williams & Wilkins; 2000. pp. 119–26.
Thomas J, Jones G, Scarinci I, Brantley P. A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2 diabetes and other chronic illnesses. Diabetes care. 2003 Aug 1;26(8):2311-7.
Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak—the link between depression and cardiovascular disease. Nature Reviews Cardiology. 2012 Sep;9(9):526-39.
Thayer JF, Lane RD. The role of vagal function in the risk for cardiovascular disease and mortality. Biological psychology. 2007 Feb 1;74(2):224-42.
O’Connor CM, Gurbel PA, Serebruany VL. Depression as a risk factor for cardiovascular and cerebrovascular disease: Emerging data and clinical perspectives. Am Heart J. 2000;140:S63–9.
Cai Y, Chen M, Zhai W, Wang C. Interaction between trouble sleeping and depression on hypertension in the NHANES 2005–2018. BMC public health. 2022 Dec;22(1):1-11.
Song X, Zhang Z, Zhang R, Wang M, Lin D, Li T, Shao J, Ma X. Predictive markers of depression in hypertension. Medicine. 2018 Aug;97(32).
Rueda B, Perez-Garcia AM. Coping strategies, depressive symptoms and quality of life in hypertensive patients: mediational and prospective relations. Psychology & health. 2013 Oct 1;28(10):1152-70.
Saboya PM, Zimmermann PR, Bodanese LC. Association between anxiety or depressive symptoms and arterial hypertension, and their impact on the quality of life. The International Journal of Psychiatry in Medicine. 2010 Sep;40(3):307-20.
Batal O, Khatib OF, Bair N, Aboussouan LS, Minai OA. Sleep quality, depression, and quality of life in patients with pulmonary hypertension. Lung. 2011 Apr;189:141-9.
Maguire LK, Hughes CM, McElnay JC. Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension—a primary care study. Patient education and counseling. 2008 Nov 1;73(2):371-6.
Moise N, Davidson KW, Chaplin W, Shea S, Kronish I. Depression and clinical inertia in patients with uncontrolled hypertension. JAMA internal medicine. 2014 May 1;174(5):818-9.
Oganov RG, Pogosova GV, Koltunov IE, Romasenko LV, Deev AD, IuM I. Depressive symptoms worsen cardiovascular prognosis and shorten length of life in patients with arterial hypertension and ischemic heart disease. Kardiologiia. 2011 Jan 1;51(2):59-66.
Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. Jama. 1989 Aug 18;262(7):914-9.
Wang L, Li J. Role of educational intervention in the management of comorbid depression and hypertension. Blood pressure. 2003 Jan 1;12(4):198-202.
Coventry P. Multicondition collaborative care intervention for people with coronary heart disease and/or diabetes, depression and poor control of hypertension, blood sugar or hypercholesterolemia improves disability and quality of life compared with usual care. BMJ Evidence-Based Medicine. 2012 Dec 1;17(6):e13.
Rabkin JG, Charles E, Kass F. Hypertension and DSM-III depression in psychiatric outpatients. The American journal of psychiatry. 1983 Aug 1;140(8):1072-4.
Rubio-Guerra AF, Arceo-Navarro A, Lozano-Nuevo JJ, Vargas-Ayala G, Rodríguez-López L, Ramos-Brizuela LM. Efficacy of a fixed-dose combination of trandolapril-verapamil in patients with stage 2 hypertension inadequately controlled by monotherapy. Clinical drug investigation. 2005 Jul;25:445-51.
Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?. Journal of hypertension. 2007 Oct 1;25(10):2117-24
Dhar AK, Barton DA. Depression and the link with cardiovascular disease. Frontiers in psychiatry. 2016 Mar 21;7:33.
Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. Journal of the American College of Cardiology. 1995 Nov 1;26(5):1257-63.
Pitzalis MV, Iacoviello M, Todarello O, Fioretti A, Guida P, Massari F, Mastropasqua F, Russo GD, Rizzon P. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. American heart journal. 2001 May 1;141(5):765-71.
Jha MK, Qamar A, Vaduganathan M, Charney DS, Murrough JW. Screening and management of depression in patients with cardiovascular disease: JACC state-of-the-art review. Journal of the American College of Cardiology. 2019 Apr 16;73(14):1827-45.
Singla S, Jhamb S, Singh KD, Kumar A. Depression affects autonomic system of the body? Yes, it does!. Journal of education and health promotion. 2020 Jan 1;9(1):217.
Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti Jr TD, DeBellis MD, Rice KC. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proceedings of the National Academy of Sciences. 2000 Jan 4;97(1):325-30.
Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. The American journal of cardiology. 2002 Dec 15;90(12):1279-83.
Lichtman JH, Bigger Jr JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008 Oct 21;118(17):1768-75.
Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA psychiatry. 2018 Apr 1;75(4):336-46.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Kardiologia Polska (Polish Heart Journal). 2016;74(10):1037-147.
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez Sanchez MA, Jaarsma T. Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012= ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Revista Española de Cardiología. 2012;65(10):938.
Pettinger R. Stress management. New York: Capstone; 2002 Apr.
Greenberg J. Comprehensive stress management. McGraw-Hill Education; 2012.
Van den Bergh O. Principles and practice of stress management. Guilford Publications; 2021 Jun 14.
Smith JC. Stress management: A comprehensive handbook of techniques and strategies. Springer Publishing Company; 2002.
Pekala RJ, Forbes EJ. Subjective effects of several stress management strategies: With reference to attention. Behavioral Medicine. 1990 Mar 1;16(1):39-43.
Pase MP. Dietary Approaches to Reduce Aortic Stiffness. Handbook of Lipids in Human Function. 2016 Jan 1:141-61.
Ho AK, Bartels CM, Thorpe CT, Pandhi N, Smith MA, Johnson HM. Achieving weight loss and hypertension control among obese adults: a US multidisciplinary group practice observational study. American journal of hypertension. 2016 Aug 1;29(8):984-91.
Edenfield TM, Blumenthal JA. Exercise and stress reduction. The handbook of stress science: Biology, psychology, and health. 2011:301-19.
Blumenthal JA, Babyak MA, Carney RM, Huber M, Saab PG, Burg MM, Sheps D, Powell L, Taylor CB, Kaufmann PG. Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Medicine and Science in Sports and Exercise. 2004 May 1;36(5):746-55.
El-Atat F, Aneja A, Mcfarlane S, Sowers J. Obesity and hypertension. Endocrinol Metab Clin North Am. 2003;32:823-54.
Talukder MH, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, Liu X, Zweier JL. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. American Journal of Physiology-Heart and Circulatory Physiology. 2011 Jan;300(1):H388-96.
Tuomilehto J, Elo J, Nissinen A. Smoking among patients with malignant hypertension. British Medical Journal (Clinical research ed.). 1982 Apr 4;284(6322):1086.
Dahl LK, Leitl G, Heine M. Influence of dietary potassium and sodium/potassium molar ratios on the development of salt hypertension. The Journal of experimental medicine. 1972 Aug 8;136(2):318.
Parker K, He J, Cutler A. Potassium and blood pressure. MJIM. 2003;275:1620-32.
https://my.clevelandclinic.org/health/treatments/9301-antidepressants-depression-medication
https://www.mayoclinic.org/diseases-conditions/depression/diagnosis-treatment/drc-20356013